日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.

Galunisertib (LY2157299) 阻断 TGFβR1 可增强抗 GD2 抗体 Dinutuximab (ch14.18) 与自然杀伤细胞的抗神经母细胞瘤活性

Tran Hung C, Wan Zesheng, Sheard Michael A, Sun Jianping, Jackson Jeremy R, Malvar Jemily, Xu Yibing, Wang Larry, Sposto Richard, Kim Eugene S, Asgharzadeh Shahab, Seeger Robert C

Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy

从神经母细胞瘤患儿体内分离并激活自然杀伤细胞,用于过继细胞治疗

Liu, Yin; Wu, Hong-Wei; Sheard, Michael A; Sposto, Richard; Somanchi, Srinivas S; Cooper, Laurence J N; Lee, Dean A; Seeger, Robert C

Membrane-bound TRAIL supplements natural killer cell cytotoxicity against neuroblastoma cells.

膜结合型 TRAIL 可增强自然杀伤细胞对神经母细胞瘤细胞的细胞毒性

Sheard Michael A, Asgharzadeh Shahab, Liu Yin, Lin Tsen-Yin, Wu Hong-Wei, Ji Lingyun, Groshen Susan, Lee Dean A, Seeger Robert C